GENEVA, Sept. 18 -- MOR RESEARCH APPLICATIONS LTD. filed a patent application (IL2026/050196) for “COMBINATIONS CANCER THERAPIES INCLUDING DEIODINASE 3 ENZYME (DIO3) INHIBITION”. With publication no. WO/2026/185849, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/40
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....